+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

X-Linked Myotubular Myopathy (XLMTM) - Pipeline Insight, 2025 - Product Thumbnail Image

X-Linked Myotubular Myopathy (XLMTM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Xlinked Hypophosphatemia (XLH) - Pipeline Insight, 2025 - Product Thumbnail Image

Xlinked Hypophosphatemia (XLH) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Xerostomia - Pipeline Insight, 2025 - Product Thumbnail Image

Xerostomia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Wet Age-Related Macular Degeneration (Wet-AMD)- Pipeline Insight, 2025 - Product Thumbnail Image

Wet Age-Related Macular Degeneration (Wet-AMD)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Warts - Pipeline Insight, 2025 - Product Thumbnail Image

Warts - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Visual Cycle Modulation (VCM) - Pipeline Insight, 2025 - Product Thumbnail Image

Visual Cycle Modulation (VCM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Visceral Pain Associated With GI Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Visceral Pain Associated With GI Disorders - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ventricular Dysfunction - Pipeline Insight, 2025 - Product Thumbnail Image

Ventricular Dysfunction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vascular Malformations- Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Malformations- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Varicose Veins - Pipeline Insight, 2025 - Product Thumbnail Image

Varicose Veins - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Usher Syndrome Type 2 - Pipeline Insight, 2025 - Product Thumbnail Image

Usher Syndrome Type 2 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Uncontrolled Bleeding - Pipeline Insight, 2025 - Product Thumbnail Image

Uncontrolled Bleeding - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ulcerative Colitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Tuberous Sclerosis Complex - Pipeline Insight, 2025 - Product Thumbnail Image

Tuberous Sclerosis Complex - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Trichotillomania (TTM) - Pipeline Insight, 2025 - Product Thumbnail Image

Trichotillomania (TTM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Transverse Myelitis - Pipeline Insight, 2025 - Product Thumbnail Image

Transverse Myelitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Transient Ischemic Attack - Pipeline Insight, 2025 - Product Thumbnail Image

Transient Ischemic Attack - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tinea Pedis - Pipeline Insight, 2025 - Product Thumbnail Image

Tinea Pedis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Metabolic Acidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Metabolic Acidosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Metachromatic Leukodystrophy (MLD) - Pipeline Insight, 2025 - Product Thumbnail Image

Metachromatic Leukodystrophy (MLD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more